Tramazoline

You can help expand this article with text translated from the corresponding article in German. (December 2017) Click [show] for important translation instructions. View a machine-translated version of the German article. Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia. Consider adding a topic to this template: there are already 2,344 articles in the main category, and specifying|topic= will aid in categorization. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing German Wikipedia article at [[:de:Tramazolin]]; see its history for attribution. You may also add the template {{Translated|de|Tramazolin}} to the talk page. For more guidance, see Wikipedia:Translation.

Tramazoline

Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	R01AA09 (WHO)
Identifiers
IUPAC name N-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine
CAS Number	1082-57-1 N
PubChem CID	5524
ChemSpider	5323 N
UNII	SLE31693IV
KEGG	D08624 N
ChEMBL	ChEMBL32573 N
CompTox Dashboard (EPA)	DTXSID5046936
ECHA InfoCard	100.012.823
Chemical and physical data
Formula	C13H17N3
Molar mass	215.300 g·mol−1
NY (what is this?)  (verify)

Tramazoline is a chemical that is used in the form of tramazoline hydrochloride in nasal decongestant preparations.^[1] It is an α-adrenergic receptor agonist that inhibits secretion of nasal mucus.

It was patented in 1961 and came into medical use in 1962.^[2]